HARBOR CAPITAL ADVISORS, INC.

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1039128 CHICAGO, IL

Position in TARS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,863,779

-$190,423 QoQ

Shares Held

29,612

+1.1% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#107

of 257 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR CAPITAL ADVISORS, INC. holds $28,134,645 across 28 Biotechnology names. TARS ranks #6 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	36,368	$4,170,318
2	VCEL	Vericel Corp	72,852	$3,241,185
3	HALO	Halozyme Therapeutics, Inc.	36,977	$2,894,189
4	RARE	Ultragenyx Pharmaceutical Inc.	72,316	$2,414,631
5	CELC	Celcuity Inc.	19,933	$2,085,390
6	TARS	Tarsus Pharmaceuticals, Inc. This page	29,612	$1,863,779
7	AGIO	Agios Pharmaceuticals, Inc.	46,550	$1,727,470
8	SRPT	Sarepta Therapeutics, Inc.	92,669	$1,665,261

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,863,779	29,612	+1.1%	Shares	Sole	2026-08-07
2026-03-31	$2,054,202	29,283	+34.8%	Shares	Sole	2026-04-28
2025-12-31	$1,778,597	21,722	+39.4%	Shares	Sole	2026-01-20
2025-09-30	$926,394	15,588	-35.8%	Shares	Sole	2025-10-15
2025-06-30	$983,056	24,267	+16.8%	Shares	Sole	2025-07-09
2025-03-31	$1,066,852	20,768	-6.1%	Shares	Sole	2025-04-14
2024-12-31	$1,224,396	22,113	+22.1%	Shares	Sole	2025-01-10
2024-09-30	$595,473	18,105	+57.5%	Shares	Sole	2024-10-29
2024-06-30	$312,379	11,493	-1.1%	Shares	Sole	2024-07-09
2024-03-31	$422,387	11,620	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.